News Novartis agrees $5.7bn degrader deal with Monte Rosa Novartis has signed its second multibillion-dollar licensing deal with molecular glue degrader specialist Monte Rosa in less than a year.
News Lilly offers AI discovery models to biotech partners Eli Lilly is offering AI-powered drug discovery models developed at a cost of around $1 billion to biotech companies for free.
Market Access Why impactful and scalable global Medical Information (MI) p... A trusted MI partner ensures compliance with global and local regulations and provides consistent access to accurate medical information.
Sales & Marketing 5 Things to watch at Fierce Pharma Week 2025: What every pha... Fierce Pharma Week 2025, 8th to 11th September 2025 in Philadelphia marks a historic shift in pharmaceutical industry events.
News OMass attracts $420m Roche wager on IBD programme UK biotech OMass has revealed its first major pharma partnership, with Roche paying $20m upfront for an inflammatory bowel disease programme.
News Novo reels in Replicate for new cardiometabolic drugs Replicate will receive up to $550m from Novo Nordisk in an alliance that aims to deliver a new generation of drugs for obesity and diabetes.
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.